
Tectochrysin, a natural compound from propolis, reduced the viability and proliferation of colorectal cancer cells in laboratory experiments and reduced tumor activity and metastases in the liver and lungs in mice by suppressing signaling pathways through the ERBB4 protein, but its effect in humans has not yet been studied.
AI-generated summary
Tectochrysin is a natural compound found in propolis, a bee product. Colorectal cancer is one of the most common forms of cancer. Previous studies have already pointed to the potential anti-cancer properties of propolis components.
The natural compound tectochrysin, found in propolis, was able to slow down the development of colorectal cancer and the formation of metastases in animal experiments. The study results were published in the journal Food & Function (F&F).
In experiments on colorectal cancer cells, tectochrysin reduced their viability and ability to multiply, move, and penetrate surrounding tissues. In addition, the substance prevented the formation of new blood vessels necessary for tumor growth.
The effect was confirmed in mice. Tectochrysin reduced tumor activity and reduced the number of metastatic foci in the liver and lungs. There were also fewer blood vessels in the tumor tissue.
Researchers linked the effect of the substance to the ERBB4 protein, which is involved in transmitting signals that promote the growth and spread of tumor cells. Tectochrysin interacted with this protein and suppressed the signaling pathways associated with it.
So far, the antitumor effect of tectochrysin has been shown only in laboratory experiments and in animals. Before talking about possible use in humans, scientists will have to study its absorption, safety and effectiveness.
AI outlook — possibilities, not facts
Preclinical studies of tectochrysin will be conducted to evaluate its safety and pharmacokinetics
Likely · Within months
If preclinical data are favorable, phase I clinical trials in healthy volunteers will follow.
Possible · Within years

A Vanderbilt University Medical Center study found that empagliflozin reduced inflammatory monocyte and platelet aggregates in obese women with prediabetes after just two weeks, an effect that increased over three months and was not observed in the low-calorie diet group, suggesting a direct anti-inflammatory effect of the drug beyond weight loss.

A study from the University of York found that sleeping less than seven or more than eight hours a night increases the risk of developing dementia. Low physical activity and long periods of time spent in a sitting position also affect the likelihood of the disease.

Director of the National Medical Research Center for Endocrinology Natalya Mokrysheva said that in the coming decades the creation of a universal cure for diabetes is impossible due to the lack of a single monogenic cause of the disease.

A study published in the journal Science found that hypertension accelerates osteoarthritis through the hormone vasopressin. Scientists have found that blocking AVPR1A receptors in joints can prevent cartilage breakdown caused by high blood pressure.

Deputy Minister of Health of the Russian Federation Sergei Glagolev said that the increase in prices for vital and essential medicines in Russia remains below the inflation rate.

Russian sanitary watchdog Rospotrebnadzor has offered to assist the United States in managing recent outbreaks of infectious diseases, including measles, typhus, and plague, citing Russia's experience in epidemiological control.